Jordan Ellis
The pharmaceutical supply chain involves the process of sourcing raw materials, manufacturing, distributing, and delivering medications to patients. The key stakeholders in the pharmaceutical industry supply chain include raw material suppliers, drug manufacturers, regulatory agencies, wholesale distributors, pharmacies, pharmacy benefit managers (PBMs), healthcare providers, and patients. Hospitals play a crucial role in the pharmaceutical supply chain by dispensing specialty medications to patients and ensuring that they have access to the necessary drugs. However, hospitals may face challenges in obtaining certain specialty drugs due to restricted distribution by drug manufacturers. To overcome this, hospital networks are partnering with specialty pharmacy programs and accreditors to ensure they meet the required standards for dispensing these medications.
| Characteristics | Values |
|---|---|
| Pharmaceutical supply chain stakeholders | Raw material suppliers, drug manufacturers, regulatory agencies, wholesale distributors, pharmacies, pharmacy benefit managers (PBMs), healthcare providers, and patients |
| Pharmaceutical manufacturers' customers | Drug wholesalers, retail chains, mail-order and specialty pharmacies, hospital chains, and health plans |
| Pharmaceutical manufacturers' influence | Pharmaceutical prices, expected demand, future competition, and projected marketing costs |
| Pharmaceutical supply chain strategies | Drug manufacturing, transfer to wholesale distributors, stocking at pharmacies, price negotiation, quality and utilization management checks, and dispensing drugs to patients |
| Pharmacy Benefit Managers' role | Facilitate consumer billing and payments for participants in group health benefit plans |
| Pharmacy purchasing | Pharmacies purchase prescription drugs from wholesalers at a contracted discount off the WAC, with rates varying based on size and purchasing power |
| Hospital specialty pharmacy programs | Hospitals assemble these programs to satisfy drug manufacturers' requirements for delivering costly, restricted distribution drugs |
| Specialty pharmacy networks for hospitals | Excelera and UHC serve as accreditors of hospital pharmacy departments, ensuring compliance with training, quality control, and patient follow-up standards |
| Pharmaceutical trade value growth | The worldwide value of pharmaceutical goods traded grew sixfold from $113 billion in 2000 to $629 billion in 2019 |
| Pharmaceutical supply chain globalisation | Companies often source critical materials from a single region, increasing vulnerability to shortages during natural disasters and conflicts |
| Pharmaceutical supply chain challenges | Lack of visibility into suppliers' practices, non-compliance with regulations, and risks associated with outsourcing and complex supply chains |
Explore related products
What You'll Learn
Hospitals' participation in specialty pharmacy networks
Hospitals participate in the pharmaceutical supply chain, which involves the process of sourcing raw materials, manufacturing, distributing, and delivering medications to patients. This supply chain network comprises various stakeholders, including raw material suppliers, drug manufacturers, regulatory agencies, wholesale distributors, pharmacies, pharmacy benefit managers (PBMs), healthcare providers, and patients. Proper coordination between these stakeholders is essential to ensure patients receive safe and effective medications.
One example of a specialty pharmacy network is Excelera, which Fairview Health Services joined to enhance its ability to dispense specialty medications within its facilities. This enables Fairview to closely monitor its patients' clinical status and medication adherence. Excelera and UHC, another hospital consortium, act as accreditors of hospital pharmacy departments, ensuring they meet training, quality control, and patient follow-up standards. They also simplify the data input process for drug manufacturers by serving as a single point of contact.
Another illustration is the Biogen Idec's Alternate Care Pharmacy Network program, which expands the network for Tecfidera, a specialty drug for MS patients, to include hospital outpatient specialty pharmacies. This expansion addresses the increased demand for Tecfidera and enables hospitals to access this specialty medication. However, the specific criteria and evaluation process for pharmacy inclusion in the Tecfidera network are not disclosed.
While specialty pharmacy networks offer benefits, challenges exist. PBMs often impose onerous terms and conditions on providers seeking access to these networks, requiring them to service a diverse range of specialty drug products. Additionally, limited distribution drugs, which are typically accessible to only a few pharmacies, create barriers to entry for hospitals and health-system pharmacies. To overcome these challenges, health-system pharmacies should explore solutions such as demonstrating positive patient outcomes, developing robust policies and procedures, and leveraging applicable laws to gain entry into restrictive specialty networks.
Religious Exemptions: Hospital Acceptance and Your Rights
You may want to see also
Explore related products
Hospitals as stakeholders in the pharma supply chain
Hospitals are integral stakeholders in the pharmaceutical supply chain. They are the final link in the chain, delivering medications to patients. The pharmaceutical supply chain involves the interconnected processes of sourcing raw materials, manufacturing, distributing, and delivering medications to patients. It is a complex process with many key components and stakeholders, all of whom must work together to ensure the timely and efficient delivery of life-saving medications.
The supply chain begins with raw material suppliers, who source the materials needed to create pharmaceutical products. These materials are then manufactured into finished products by drug manufacturers, who have the most influence over pharmaceutical prices. These manufacturers distribute drugs to wholesalers or directly to pharmacies, including retail chains, mail-order, and specialty pharmacies, as well as hospital chains. Wholesale distributors then purchase these pharmaceutical products and distribute them to a range of customers, including hospitals.
Hospitals play a crucial role in this supply chain as they are responsible for dispensing drugs to patients and monitoring their clinical status. In some cases, hospitals may also act as pharmacies, dispensing medications directly to patients. This is particularly relevant for specialty drugs, which may have restricted distribution and require a specialty pharmacy network to deliver them to patients. For example, a patient visiting a hematology clinic may receive a prescription for a specialty drug. The clinic sends the prescription to a third-party hub, which passes it on to a specialty pharmacy that mails the drug to the patient.
Hospitals, as stakeholders, also engage with other stakeholders in the pharmaceutical supply chain, such as patients, healthcare providers, and regulatory agencies. They provide feedback on the quality and effectiveness of medications and work to ensure the safe and timely delivery of medications to patients. Hospitals also play a role in maintaining public health, especially during emergencies, by providing access to essential medications. Furthermore, hospitals can influence the development and availability of new drugs by partnering with pharmaceutical companies and advocating for their patients' needs.
The High Cost of Hospital Stays: CT Scans
You may want to see also
Explore related products
Hospitals' role in ensuring patient access to drugs
Hospitals play a crucial role in ensuring patient access to drugs, which is a complex process involving many stakeholders in the pharmaceutical supply chain. This process includes sourcing raw materials, manufacturing, distributing, and delivering medications to patients.
One of the primary ways hospitals ensure patient access to drugs is by maintaining relationships with pharmaceutical manufacturers and wholesalers. Pharmaceutical manufacturers supply finished products directly to hospital chains, and wholesalers distribute drugs to hospitals and other customers. Hospitals also work with pharmacy benefit management companies that negotiate prices and process drugs through quality and utilization management checks.
To ensure patient safety and access to the right medications, hospitals must implement robust medication security and handling procedures. This includes storing controlled substances in secure, locked facilities with limited access restricted to authorized personnel only. Hospitals are required to conduct regular inventories of controlled substances, maintain detailed records from procurement to disposal, and properly dispose of expired or unused medications.
Hospitals also play a role in participating in clinical trials and expanded access programs to provide patients with investigational drugs for serious or life-threatening diseases or conditions. Additionally, hospitals aim to prevent medication errors, which can include incorrect medication, timing, or dosage. Strategies to reduce errors include ongoing training for staff, clear and complete medication orders, access to up-to-date drug information, and implementing safety checks.
Furthermore, hospitals are increasingly involved in specialty pharmacy networks to improve access to specialty medications within their facilities. This enables hospitals to dispense specialty drugs directly to patients and maintain closer track of their clinical status.
Trump's VA Hospitals: Closure or Care?
You may want to see also
Explore related products
Hospitals' relationship with pharma manufacturers
Hospitals and pharmaceutical manufacturers have traditionally viewed themselves as transactional partners. However, this relationship is evolving, with hospitals becoming part of larger health systems and gaining more negotiating power. Hospitals are now exploring risk-based contracts with pharmaceutical companies that link drug prices to their effectiveness in patients. Hospitals are also collaborating with pharmaceutical companies on digital health tools to improve patient care and medication adherence.
Hospitals are significant stakeholders in the pharmaceutical supply chain, which involves sourcing raw materials, manufacturing, distributing, and delivering medications to patients. Pharmaceutical manufacturers supply finished products to meet demand from the healthcare sector, distributing drugs to wholesalers or directly to pharmacies, including hospital chains.
The relationship between hospitals and pharmaceutical companies has been strained by public criticism of the industry's pricing practices and ethical concerns about the influence of industry funding on physicians' prescribing habits. To address these challenges, some hospitals are partnering with pharmaceutical companies to improve patient outcomes and reduce costs.
For example, hospitals are assembling specialty pharmacy programs to meet drug manufacturers' requirements for delivering costly, restricted-distribution drugs. Additionally, initiatives like Excelera and UHC aim to accredit hospital pharmacy departments, ensuring they meet quality standards and allowing drug manufacturers to deal with a single entity for data input.
Overall, hospitals and pharmaceutical manufacturers are moving beyond transactional relationships towards collaborations that aim to improve patient care, increase medication adherence, and address challenges in the pharmaceutical supply chain. These partnerships have the potential to benefit both parties and, most importantly, the patients they serve.
The Evolution of Doctor and Nurse Attire
You may want to see also
Explore related products
Hospitals' influence on pharma supply chain resilience
Hospitals are key stakeholders in the pharmaceutical supply chain, which involves the process of sourcing raw materials, manufacturing, distributing, and delivering medications to patients. They play a critical role in ensuring the resilience of the pharmaceutical supply chain, which is essential for maintaining the continuity of healthcare systems. Disruptions in the pharmaceutical supply chain, especially during global crises such as the COVID-19 pandemic, can lead to severe shortages of essential medical products, compromising patient care and public health.
Hospitals influence the resilience of the pharmaceutical supply chain in several ways. Firstly, they serve as a vital link between drug manufacturers and patients. Hospitals often have their own pharmacies or collaborate with external specialty pharmacies to procure and dispense medications to patients. This direct involvement in the distribution and delivery stages of the supply chain makes hospitals accountable for ensuring the availability and accessibility of medications for their patients.
Secondly, hospitals contribute to the resilience of the pharmaceutical supply chain by monitoring drug inventory and addressing shortages. Hospital pharmacy teams are often the first to notice drug shortages and play a crucial role in mitigating these shortages within their institutions. They may recommend alternative medications to prescribers, contact alternative suppliers, or update their formularies to ensure that patients continue to receive the medications they need. This proactive approach helps to prevent or minimize the impact of drug shortages on patient care.
Additionally, hospitals can enhance the resilience of the pharmaceutical supply chain by developing and implementing contingency plans. As end users of medical products, hospitals have a critical role in reducing the impact of shortages on patient and community health. This involves collaborating with other stakeholders, such as manufacturers and distributors, to ensure a consistent supply of medications, especially during emergencies or crises. Hospitals can also advocate for information sharing and transparency within the supply chain, which facilitates better coordination and more effective decision-making during disruptions.
Furthermore, hospitals can influence the resilience of the pharmaceutical supply chain by participating in specialty pharmacy networks and accrediting bodies. For example, hospitals may join networks like Excelera and UHC, which serve as accreditors of hospital pharmacy departments, ensuring they meet training, quality control, and patient follow-up standards. By participating in these networks, hospitals can improve their ability to dispense specialty medications, maintain high standards of patient care, and keep closer track of the clinical status of their patients.
In conclusion, hospitals play a significant role in influencing the resilience of the pharmaceutical supply chain. Their involvement in medication procurement, dispensing, and inventory management helps ensure the availability and accessibility of medications for patients. Additionally, hospitals contribute to the development and implementation of contingency plans during shortages, protecting patient and community health. By collaborating with other stakeholders, advocating for transparency, and participating in specialty pharmacy networks, hospitals enhance the resilience of the pharmaceutical supply chain, ultimately improving patient care and public health outcomes.
The Logistics of Moving the Deceased in Hospitals
You may want to see also
Frequently asked questions
Yes, hospitals are a part of the pharma supply chain. They are included in the chain as they dispense drugs to patients, who take them as prescribed.
The pharma supply chain involves the process of sourcing raw materials, manufacturing, distributing, and delivering medications to patients.
The key stakeholders in the pharmaceutical supply chain include raw material suppliers, drug manufacturers, regulatory agencies, wholesale distributors, pharmacies, pharmacy benefit managers (PBMs), healthcare providers, and patients.
The pharmaceutical supply chain faces several challenges, including supply chain visibility, drug counterfeiting, cold-chain shipping, and rising prescription drug prices, which increase out-of-pocket patient costs.
Hospitals obtain specialty drugs through specialty pharmacy networks. These networks ensure that hospitals can dispense specialty medications within their facilities and keep closer track of the clinical status of patients.
